Hydroxychloroquine

Through the fog of alleged misconduct, hope, hype, and politicization that surrounds hydroxychloroquine, the malaria drug touted as a COVID-19 treatment, a scientific picture is now emerging - Kai Kupferschmidt

Hydroxychloroquine

image by: Hydroxychloroquine

HWN Recommends

Hydroxychloroquine can’t stop COVID-19. It’s time to move on, scientists say

As a frontline doctor working with COVID-19 patients at Columbia University Medical Center in New York City, Neil Schluger had horrific days.

“I would come into the ward in the morning to make rounds and say to the intern, ‘How did we do last night?’ And the intern said, ‘Well, I had 10 COVID admissions, and three of them have already died.’ It was like nothing I’ve experienced in 35 years of being a physician,” Schluger says.

When he first heard about hydroxychloroquine, he hoped it would work for his patients. He and colleagues prescribed the antimalarial drug for 811 of the 1,446 patients hospitalized at the medical center from March 7 to April 8. But the drug didn’t seem…

read full article

Resources

A French doctor finds fame promoting malaria pills for covid-19

In late march, outside a brand-new medical institute on a busy boulevard in Marseille, a single-file queue snaked along the pavement. Amid a national shortage of covid-19 tests, local residents had heard that the city’s Institut Hospitalier Universitaire, linked to the main public hospital, was offering to test anybody with even mild symptoms. Word had also spread that the institute’s director, Didier Raoult, was successfully treating patients there with hydroxychloroquine, used to treat malaria, along with an antibiotic. Today, Mr Raoult says coolly that covid-19 has “almost totally disappeared” from Marseille.

New Covid-19 study, despite flaws, adds to case against hydroxychloroquine

This trial tested using the drug right after symptoms began. In the end, only 58% of the people in this study had diagnostic test results. The researchers mailed study drug or placebo to patients without examining them after they enrolled over the internet...

Rush to trash hydroxychloroquine based on faulty Surgisphere data exposes fundamental flaws in profit-based medical ‘science’

As the WHO and prestigious medical journal the Lancet back away from questionable data provided by healthcare analytics firm Surgisphere, ulterior motives for the rush to demonize hydroxychloroquine become clear.

Three big studies dim hopes that hydroxychloroquine can treat or prevent COVID-19

Through the fog of alleged misconduct, hope, hype, and politicization that surrounds hydroxychloroquine, the malaria drug touted as a COVID-19 treatment, a scientific picture is now emerging.